Albumin	B:C0001924
-	O
Bioinspired	O
Gd	O
:	O
CuS	O
Nanotheranostic	O
Agent	O
for	O
In	O
Vivo	I:C1515655
Photoacoustic	O
/	I:C0087111
Magnetic	I:C0087111
Resonance	I:C0087111
Imaging	I:C0087111
-	I:C0087111
Guided	I:C0087111
Tumor	I:C0087111
-	I:C0087111
Targeted	I:C0087111
Photothermal	I:C0087111
Therapy	I:C0087111
.	O

Albumin	O
-	O
Bioinspired	O
Gd	B:C0016911
:	O
CuS	O
Nanotheranostic	O
Agent	O
for	O
In	O
Vivo	I:C1515655
Photoacoustic	O
/	I:C0087111
Magnetic	I:C0087111
Resonance	I:C0087111
Imaging	I:C0087111
-	I:C0087111
Guided	I:C0087111
Tumor	I:C0087111
-	I:C0087111
Targeted	I:C0087111
Photothermal	I:C0087111
Therapy	I:C0087111
.	O

Albumin	O
-	O
Bioinspired	O
Gd	O
:	O
CuS	B:C0056599
Nanotheranostic	O
Agent	O
for	O
In	O
Vivo	I:C1515655
Photoacoustic	O
/	I:C0087111
Magnetic	I:C0087111
Resonance	I:C0087111
Imaging	I:C0087111
-	I:C0087111
Guided	I:C0087111
Tumor	I:C0087111
-	I:C0087111
Targeted	I:C0087111
Photothermal	I:C0087111
Therapy	I:C0087111
.	O

Albumin	O
-	O
Bioinspired	O
Gd	O
:	O
CuS	O
Nanotheranostic	O
Agent	O
for	O
In	B:C1515655
Vivo	I:C1515655
Photoacoustic	O
/	I:C0087111
Magnetic	I:C0087111
Resonance	I:C0087111
Imaging	I:C0087111
-	I:C0087111
Guided	I:C0087111
Tumor	I:C0087111
-	I:C0087111
Targeted	I:C0087111
Photothermal	I:C0087111
Therapy	I:C0087111
.	O

Albumin	O
-	O
Bioinspired	O
Gd	O
:	O
CuS	O
Nanotheranostic	O
Agent	O
for	O
In	O
Vivo	I:C1515655
Photoacoustic	B:C0087111
/	I:C0087111
Magnetic	I:C0087111
Resonance	I:C0087111
Imaging	I:C0087111
-	I:C0087111
Guided	I:C0087111
Tumor	I:C0087111
-	I:C0087111
Targeted	I:C0087111
Photothermal	I:C0087111
Therapy	I:C0087111
.	O

Photothermal	B:C0087111
therapy	I:C0087111
(	O
Photothermal	O
therapy	I:C0087111
)	O
is	O
attracting	O
increasing	O
interest	O
and	O
becoming	O
more	O
widely	O
used	O
for	O
skin	O
cancer	I:C0920425
therapy	I:C0920425
in	O
the	O
clinic	O
,	O
as	O
a	O
result	O
of	O
its	O
noninvasiveness	O
and	O
low	O
systemic	I:C0261794
adverse	I:C0261794
effects	I:C0261794
.	O

Photothermal	O
therapy	I:C0087111
(	O
Photothermal	B:C0087111
therapy	I:C0087111
)	O
is	O
attracting	O
increasing	O
interest	O
and	O
becoming	O
more	O
widely	O
used	O
for	O
skin	O
cancer	I:C0920425
therapy	I:C0920425
in	O
the	O
clinic	O
,	O
as	O
a	O
result	O
of	O
its	O
noninvasiveness	O
and	O
low	O
systemic	I:C0261794
adverse	I:C0261794
effects	I:C0261794
.	O

Photothermal	O
therapy	I:C0087111
(	O
Photothermal	O
therapy	I:C0087111
)	O
is	O
attracting	O
increasing	O
interest	O
and	O
becoming	O
more	O
widely	O
used	O
for	O
skin	B:C0920425
cancer	I:C0920425
therapy	I:C0920425
in	O
the	O
clinic	O
,	O
as	O
a	O
result	O
of	O
its	O
noninvasiveness	O
and	O
low	O
systemic	I:C0261794
adverse	I:C0261794
effects	I:C0261794
.	O

Photothermal	O
therapy	I:C0087111
(	O
Photothermal	O
therapy	I:C0087111
)	O
is	O
attracting	O
increasing	O
interest	O
and	O
becoming	O
more	O
widely	O
used	O
for	O
skin	O
cancer	I:C0920425
therapy	I:C0920425
in	O
the	O
clinic	B:C0442592
,	O
as	O
a	O
result	O
of	O
its	O
noninvasiveness	O
and	O
low	O
systemic	I:C0261794
adverse	I:C0261794
effects	I:C0261794
.	O

Photothermal	O
therapy	I:C0087111
(	O
Photothermal	O
therapy	I:C0087111
)	O
is	O
attracting	O
increasing	O
interest	O
and	O
becoming	O
more	O
widely	O
used	O
for	O
skin	O
cancer	I:C0920425
therapy	I:C0920425
in	O
the	O
clinic	O
,	O
as	O
a	O
result	O
of	O
its	O
noninvasiveness	O
and	O
low	B:C0261794
systemic	I:C0261794
adverse	I:C0261794
effects	I:C0261794
.	O

However	O
,	O
there	O
is	O
an	O
urgent	O
need	O
to	O
develop	O
biocompatible	O
PTT	O
agents	O
,	O
which	O
enable	O
accurate	O
imaging	B:C0011923
,	O
monitoring	O
,	O
and	O
diagnosis	O
.	O

However	O
,	O
there	O
is	O
an	O
urgent	O
need	O
to	O
develop	O
biocompatible	O
PTT	O
agents	O
,	O
which	O
enable	O
accurate	O
imaging	O
,	O
monitoring	B:C1283169
,	O
and	O
diagnosis	O
.	O

However	O
,	O
there	O
is	O
an	O
urgent	O
need	O
to	O
develop	O
biocompatible	O
PTT	O
agents	O
,	O
which	O
enable	O
accurate	O
imaging	O
,	O
monitoring	O
,	O
and	O
diagnosis	B:C0011900
.	O

Herein	O
,	O
a	O
biocompatible	O
Gd	B:C0016911
-	O
integrated	O
CuS	O
nanotheranostic	O
agent	O
(	O
Gd	O
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
)	O
was	O
synthesized	O
via	O
a	O
facile	O
and	O
environmentally	O
friendly	O
biomimetic	O
strategy	O
,	O
using	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
(	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
)	O
as	O
a	O
biotemplate	O
at	O
physiological	O
temperature	O
.	O

Herein	O
,	O
a	O
biocompatible	O
Gd	O
-	O
integrated	O
CuS	B:C0056599
nanotheranostic	O
agent	O
(	O
Gd	O
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
)	O
was	O
synthesized	O
via	O
a	O
facile	O
and	O
environmentally	O
friendly	O
biomimetic	O
strategy	O
,	O
using	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
(	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
)	O
as	O
a	O
biotemplate	O
at	O
physiological	O
temperature	O
.	O

Herein	O
,	O
a	O
biocompatible	O
Gd	O
-	O
integrated	O
CuS	O
nanotheranostic	O
agent	O
(	O
Gd	B:C0016911
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
)	O
was	O
synthesized	O
via	O
a	O
facile	O
and	O
environmentally	O
friendly	O
biomimetic	O
strategy	O
,	O
using	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
(	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
)	O
as	O
a	O
biotemplate	O
at	O
physiological	O
temperature	O
.	O

Herein	O
,	O
a	O
biocompatible	O
Gd	O
-	O
integrated	O
CuS	O
nanotheranostic	O
agent	O
(	O
Gd	O
:	O
CuS	B:C0056599
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
)	O
was	O
synthesized	O
via	O
a	O
facile	O
and	O
environmentally	O
friendly	O
biomimetic	O
strategy	O
,	O
using	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
(	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
)	O
as	O
a	O
biotemplate	O
at	O
physiological	O
temperature	O
.	O

Herein	O
,	O
a	O
biocompatible	O
Gd	O
-	O
integrated	O
CuS	O
nanotheranostic	O
agent	O
(	O
Gd	O
:	O
CuS	O
@	O
bovine	B:C0036774
serum	I:C0036774
albumin	I:C0036774
)	O
was	O
synthesized	O
via	O
a	O
facile	O
and	O
environmentally	O
friendly	O
biomimetic	O
strategy	O
,	O
using	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
(	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
)	O
as	O
a	O
biotemplate	O
at	O
physiological	O
temperature	O
.	O

Herein	O
,	O
a	O
biocompatible	O
Gd	O
-	O
integrated	O
CuS	O
nanotheranostic	O
agent	O
(	O
Gd	O
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
)	O
was	O
synthesized	O
via	O
a	O
facile	O
and	O
environmentally	O
friendly	O
biomimetic	O
strategy	O
,	O
using	O
bovine	B:C0036774
serum	I:C0036774
albumin	I:C0036774
(	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
)	O
as	O
a	O
biotemplate	O
at	O
physiological	O
temperature	O
.	O

Herein	O
,	O
a	O
biocompatible	O
Gd	O
-	O
integrated	O
CuS	O
nanotheranostic	O
agent	O
(	O
Gd	O
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
)	O
was	O
synthesized	O
via	O
a	O
facile	O
and	O
environmentally	O
friendly	O
biomimetic	O
strategy	O
,	O
using	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
(	O
bovine	B:C0036774
serum	I:C0036774
albumin	I:C0036774
)	O
as	O
a	O
biotemplate	O
at	O
physiological	O
temperature	O
.	O

The	O
as	O
-	O
prepared	O
Gd	B:C0016911
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
nanoparticles	O
(	O
NPs	O
)	O
with	O
ultrasmall	O
sizes	O
(	O
ca.	O
9	O
nm	O
)	O
exhibited	O
high	O
photothermal	O
conversion	I:C0243095
efficiency	I:C0243095
and	O
good	O
photostability	O
under	O
near	O
-	O
infrared	O
(	O
NIR	O
)	O
laser	O
irradiation	O
.	O

The	O
as	O
-	O
prepared	O
Gd	O
:	O
CuS	B:C0056599
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
nanoparticles	O
(	O
NPs	O
)	O
with	O
ultrasmall	O
sizes	O
(	O
ca.	O
9	O
nm	O
)	O
exhibited	O
high	O
photothermal	O
conversion	I:C0243095
efficiency	I:C0243095
and	O
good	O
photostability	O
under	O
near	O
-	O
infrared	O
(	O
NIR	O
)	O
laser	O
irradiation	O
.	O

The	O
as	O
-	O
prepared	O
Gd	O
:	O
CuS	O
@	O
bovine	B:C0036774
serum	I:C0036774
albumin	I:C0036774
nanoparticles	O
(	O
NPs	O
)	O
with	O
ultrasmall	O
sizes	O
(	O
ca.	O
9	O
nm	O
)	O
exhibited	O
high	O
photothermal	O
conversion	I:C0243095
efficiency	I:C0243095
and	O
good	O
photostability	O
under	O
near	O
-	O
infrared	O
(	O
NIR	O
)	O
laser	O
irradiation	O
.	O

The	O
as	O
-	O
prepared	O
Gd	O
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
nanoparticles	O
(	O
NPs	O
)	O
with	O
ultrasmall	O
sizes	O
(	O
ca.	O
9	O
nm	O
)	O
exhibited	O
high	O
photothermal	B:C0243095
conversion	I:C0243095
efficiency	I:C0243095
and	O
good	O
photostability	O
under	O
near	O
-	O
infrared	O
(	O
NIR	O
)	O
laser	O
irradiation	O
.	O

The	O
as	O
-	O
prepared	O
Gd	O
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
nanoparticles	O
(	O
NPs	O
)	O
with	O
ultrasmall	O
sizes	O
(	O
ca.	O
9	O
nm	O
)	O
exhibited	O
high	O
photothermal	O
conversion	I:C0243095
efficiency	I:C0243095
and	O
good	O
photostability	B:C0243095
under	O
near	O
-	O
infrared	O
(	O
NIR	O
)	O
laser	O
irradiation	O
.	O

With	O
doped	B:C0016911

Gd	I:C0016911
species	I:C0016911
and	O
strong	O
tunable	O
NIR	O
absorbance	O
,	O
Gd	B:C0016911
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
NPs	O
demonstrate	O
prominent	O
tumor	O
-	I:C0011923
contrasted	I:C0011923
imaging	I:C0011923
performance	O
both	O
on	O
the	O
photoacoustic	O
and	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
modalities	O
.	O

Gd	I:C0016911
species	I:C0016911
and	O
strong	O
tunable	O
NIR	O
absorbance	O
,	O
Gd	O
:	O
CuS	B:C0056599
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
NPs	O
demonstrate	O
prominent	O
tumor	O
-	I:C0011923
contrasted	I:C0011923
imaging	I:C0011923
performance	O
both	O
on	O
the	O
photoacoustic	O
and	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
modalities	O
.	O

Gd	I:C0016911
species	I:C0016911
and	O
strong	O
tunable	O
NIR	O
absorbance	O
,	O
Gd	O
:	O
CuS	O
@	O
bovine	B:C0036774
serum	I:C0036774
albumin	I:C0036774
NPs	O
demonstrate	O
prominent	O
tumor	O
-	I:C0011923
contrasted	I:C0011923
imaging	I:C0011923
performance	O
both	O
on	O
the	O
photoacoustic	O
and	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
modalities	O
.	O

Gd	I:C0016911
species	I:C0016911
and	O
strong	O
tunable	O
NIR	O
absorbance	O
,	O
Gd	O
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
NPs	O
demonstrate	O
prominent	O
tumor	B:C0011923
-	I:C0011923
contrasted	I:C0011923
imaging	I:C0011923
performance	O
both	O
on	O
the	O
photoacoustic	O
and	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
modalities	O
.	O

Gd	I:C0016911
species	I:C0016911
and	O
strong	O
tunable	O
NIR	O
absorbance	O
,	O
Gd	O
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
NPs	O
demonstrate	O
prominent	O
tumor	O
-	I:C0011923
contrasted	I:C0011923
imaging	I:C0011923
performance	O
both	O
on	O
the	O
photoacoustic	B:C3897929
and	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
modalities	O
.	O

Gd	I:C0016911
species	I:C0016911
and	O
strong	O
tunable	O
NIR	O
absorbance	O
,	O
Gd	O
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
NPs	O
demonstrate	O
prominent	O
tumor	O
-	I:C0011923
contrasted	I:C0011923
imaging	I:C0011923
performance	O
both	O
on	O
the	O
photoacoustic	O
and	O
magnetic	B:C0024485
resonance	I:C0024485
imaging	I:C0024485
modalities	O
.	O

The	O
subsequent	O
Gd	B:C0087111
:	I:C0087111
CuS	I:C0087111
@	I:C0087111
BSA	I:C0087111
-	I:C0087111
mediated	I:C0087111
PTT	I:C0087111
result	O
shows	O
high	O
therapy	O
efficacy	I:C0243095
as	O
a	O
result	O
of	O
their	O
potent	O
NIR	O
absorption	I:C0243095
and	O
high	O
photothermal	O
conversion	I:C0243095
efficiency	I:C0243095
.	O

The	O
subsequent	O
Gd	O
:	I:C0087111
CuS	I:C0087111
@	I:C0087111
BSA	I:C0087111
-	I:C0087111
mediated	I:C0087111
PTT	I:C0087111
result	O
shows	O
high	O
therapy	B:C0243095
efficacy	I:C0243095
as	O
a	O
result	O
of	O
their	O
potent	O
NIR	O
absorption	I:C0243095
and	O
high	O
photothermal	O
conversion	I:C0243095
efficiency	I:C0243095
.	O

The	O
subsequent	O
Gd	O
:	I:C0087111
CuS	I:C0087111
@	I:C0087111
BSA	I:C0087111
-	I:C0087111
mediated	I:C0087111
PTT	I:C0087111
result	O
shows	O
high	O
therapy	O
efficacy	I:C0243095
as	O
a	O
result	O
of	O
their	O
potent	O
NIR	B:C0243095
absorption	I:C0243095
and	O
high	O
photothermal	O
conversion	I:C0243095
efficiency	I:C0243095
.	O

The	O
subsequent	O
Gd	O
:	I:C0087111
CuS	I:C0087111
@	I:C0087111
BSA	I:C0087111
-	I:C0087111
mediated	I:C0087111
PTT	I:C0087111
result	O
shows	O
high	O
therapy	O
efficacy	I:C0243095
as	O
a	O
result	O
of	O
their	O
potent	O
NIR	O
absorption	I:C0243095
and	O
high	O
photothermal	B:C0243095
conversion	I:C0243095
efficiency	I:C0243095
.	O

The	O
immune	B:C0301872
response	I:C0301872
triggered	O
by	O
Gd	O
:	I:C0087111
CuS	I:C0087111
@	I:C0087111
BSA	I:C0087111
-	I:C0087111
mediated	I:C0087111
PTT	I:C0087111
is	O
preliminarily	O
explored	O
.	O

The	O
immune	O
response	I:C0301872
triggered	O
by	O
Gd	B:C0087111
:	I:C0087111
CuS	I:C0087111
@	I:C0087111
BSA	I:C0087111
-	I:C0087111
mediated	I:C0087111
PTT	I:C0087111
is	O
preliminarily	O
explored	O
.	O

In	O
addition	O
,	O
toxicity	B:C0242890
studies	I:C0242890
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
verify	O
that	O
Gd	O
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
NPs	O
qualify	O
as	O
biocompatible	O
agents	O
.	O

In	O
addition	O
,	O
toxicity	O
studies	I:C0242890
in	O
vitro	O
and	O
in	B:C1515655
vivo	I:C1515655
verify	O
that	O
Gd	O
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
NPs	O
qualify	O
as	O
biocompatible	O
agents	O
.	O

In	O
addition	O
,	O
toxicity	O
studies	I:C0242890
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
verify	O
that	O
Gd	B:C0016911
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
NPs	O
qualify	O
as	O
biocompatible	O
agents	O
.	O

In	O
addition	O
,	O
toxicity	O
studies	I:C0242890
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
verify	O
that	O
Gd	O
:	O
CuS	B:C0056599
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
NPs	O
qualify	O
as	O
biocompatible	O
agents	O
.	O

In	O
addition	O
,	O
toxicity	O
studies	I:C0242890
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
verify	O
that	O
Gd	O
:	O
CuS	O
@	O
bovine	B:C0036774
serum	I:C0036774
albumin	I:C0036774
NPs	O
qualify	O
as	O
biocompatible	O
agents	O
.	O

A	O
biodistribution	B:C0242481
study	I:C0242481
demonstrated	O
that	O
the	O
NPs	O
can	O
undergo	O
hepatic	O
clearance	O
from	O
the	O
body	O
.	O

A	O
biodistribution	O
study	I:C0242481
demonstrated	O
that	O
the	O
NPs	O
can	O
undergo	O
hepatic	O
clearance	O
from	O
the	O
body	B:C0242821
.	O

This	O
study	O
highlights	O
the	O
practicality	O
and	O
versatility	O
of	O
albumin	B:C0001924
-	O
mediated	O
biomimetic	O
mineralization	O
of	O
a	O
nanotheranostic	O
agent	O
and	O
also	O
suggests	O
that	O
bioinspired	O
Gd	O
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
NPs	O
possess	O
promising	O
imaging	O
guidance	I:C0442972
and	O
effective	O
tumor	O
ablation	I:C0087111
properties	I:C0087111
,	O
with	O
high	O
spatial	O
resolution	O
and	O
deep	O
tissue	O
penetration	O
.	O

This	O
study	O
highlights	O
the	O
practicality	O
and	O
versatility	O
of	O
albumin	O
-	O
mediated	O
biomimetic	O
mineralization	O
of	O
a	O
nanotheranostic	O
agent	O
and	O
also	O
suggests	O
that	O
bioinspired	O
Gd	B:C0016911
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
NPs	O
possess	O
promising	O
imaging	O
guidance	I:C0442972
and	O
effective	O
tumor	O
ablation	I:C0087111
properties	I:C0087111
,	O
with	O
high	O
spatial	O
resolution	O
and	O
deep	O
tissue	O
penetration	O
.	O

This	O
study	O
highlights	O
the	O
practicality	O
and	O
versatility	O
of	O
albumin	O
-	O
mediated	O
biomimetic	O
mineralization	O
of	O
a	O
nanotheranostic	O
agent	O
and	O
also	O
suggests	O
that	O
bioinspired	O
Gd	O
:	O
CuS	B:C0056599
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
NPs	O
possess	O
promising	O
imaging	O
guidance	I:C0442972
and	O
effective	O
tumor	O
ablation	I:C0087111
properties	I:C0087111
,	O
with	O
high	O
spatial	O
resolution	O
and	O
deep	O
tissue	O
penetration	O
.	O

This	O
study	O
highlights	O
the	O
practicality	O
and	O
versatility	O
of	O
albumin	O
-	O
mediated	O
biomimetic	O
mineralization	O
of	O
a	O
nanotheranostic	O
agent	O
and	O
also	O
suggests	O
that	O
bioinspired	O
Gd	O
:	O
CuS	O
@	O
bovine	B:C0036774
serum	I:C0036774
albumin	I:C0036774
NPs	O
possess	O
promising	O
imaging	O
guidance	I:C0442972
and	O
effective	O
tumor	O
ablation	I:C0087111
properties	I:C0087111
,	O
with	O
high	O
spatial	O
resolution	O
and	O
deep	O
tissue	O
penetration	O
.	O

This	O
study	O
highlights	O
the	O
practicality	O
and	O
versatility	O
of	O
albumin	O
-	O
mediated	O
biomimetic	O
mineralization	O
of	O
a	O
nanotheranostic	O
agent	O
and	O
also	O
suggests	O
that	O
bioinspired	O
Gd	O
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
NPs	O
possess	O
promising	O
imaging	B:C0442972
guidance	I:C0442972
and	O
effective	O
tumor	O
ablation	I:C0087111
properties	I:C0087111
,	O
with	O
high	O
spatial	O
resolution	O
and	O
deep	O
tissue	O
penetration	O
.	O

This	O
study	O
highlights	O
the	O
practicality	O
and	O
versatility	O
of	O
albumin	O
-	O
mediated	O
biomimetic	O
mineralization	O
of	O
a	O
nanotheranostic	O
agent	O
and	O
also	O
suggests	O
that	O
bioinspired	O
Gd	O
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
NPs	O
possess	O
promising	O
imaging	O
guidance	I:C0442972
and	O
effective	O
tumor	B:C0087111
ablation	I:C0087111
properties	I:C0087111
,	O
with	O
high	O
spatial	O
resolution	O
and	O
deep	O
tissue	O
penetration	O
.	O

This	O
study	O
highlights	O
the	O
practicality	O
and	O
versatility	O
of	O
albumin	O
-	O
mediated	O
biomimetic	O
mineralization	O
of	O
a	O
nanotheranostic	O
agent	O
and	O
also	O
suggests	O
that	O
bioinspired	O
Gd	O
:	O
CuS	O
@	O
bovine	O
serum	I:C0036774
albumin	I:C0036774
NPs	O
possess	O
promising	O
imaging	O
guidance	I:C0442972
and	O
effective	O
tumor	O
ablation	I:C0087111
properties	I:C0087111
,	O
with	O
high	O
spatial	O
resolution	O
and	O
deep	O
tissue	B:C0040300
penetration	O
.	O

